Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.10.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Income Statement [Abstract]        
Net revenue $ 2,711,000 $ 1,201,000 $ 4,547,000 $ 1,354,000
Cost of sales 2,456,000 1,589,000 4,275,000 1,898,000
Gross income (loss) 255,000 (388,000) 272,000 (544,000)
Operating expenses:        
Selling and administrative expenses 1,604,000 807,000 3,097,000 1,483,000
Research and development 882,000 479,000 1,533,000 957,000
Total operating expenses 2,486,000 1,286,000 4,630,000 2,440,000
Operating loss (2,231,000) (1,674,000) (4,358,000) (2,984,000)
Other income (expense):        
Interest expense (693,000) (166,000) (967,000) (302,000)
Net loss $ (2,924,000) $ (1,840,000) $ (5,325,000) $ (3,286,000)
Net loss per share - basic and diluted $ (0.07) $ (0.07) $ (0.15) $ (0.13)
Weighted average number of common shares outstanding - basic and diluted 41,966,786 25,097,827 36,517,598 25,108,859